ultimo

  1. Aksjetips

    ULTIMO Ultimovacs ASA

    Ultimovacs ASA (ULTIMO) is a pharmaceutical company developing novel immunotherapies against cancer. The lead product candidate is UV1, a therapeutic cancer vaccine inducing a specific T cell response against the universal cancer antigen telomerase. UV1 may serve as a platform for use in...
Top